3rjm: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3rjm.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3rjm", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3rjm| PDB=3rjm | SCENE= }} | |||
===CASPASE2 IN COMPLEX WITH CHDI LIGAND 33c=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_21903398}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 21903398 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_21903398}} | |||
==About this Structure== | |||
[[3rjm]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3RJM OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:021903398</ref><references group="xtra"/> | |||
[[Category: Caspase-2]] | |||
[[Category: Homo sapiens]] | |||
[[Category: Abendroth, J.]] | |||
[[Category: Kiselyov, A S.]] | |||
[[Category: Lorimer, D.]] | |||
[[Category: Maillard, M.]] | |||
[[Category: Stewart, L.]] | |||
[[Category: Caspase]] | |||
[[Category: Caspase-2]] | |||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
[[Category: P12]] | |||
[[Category: P19]] | |||
Revision as of 06:03, 21 September 2011
CASPASE2 IN COMPLEX WITH CHDI LIGAND 33c
Template:ABSTRACT PUBMED 21903398
About this Structure
3rjm is a 6 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M, Munoz-Sanjuan I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C. Exploiting differences in caspase-2 and -3 S(2) subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorg Med Chem. 2011 Oct 1;19(19):5833-51. Epub 2011 Aug 16. PMID:21903398 doi:10.1016/j.bmc.2011.08.020
